Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VIVO - Meridian Bioscience Inc.


Close
33.97
0   0%

Share volume: 0
Last Updated: Mon 30 Jan 2023 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$33.97
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2021-12-31 2022-03-31 2022-06-30 2022-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022
Report Date 2022-02-04 2022-05-06 2022-08-05 2022-11-22
Total revenue 88.341 M 111.231 M 67.771 M 65.675 M
Cost of revenue 39.182 M 42.754 M 31.043 M 31.683 M
Gross profit 49.159 M 68.477 M 36.728 M 33.992 M
    39.30% -46.36% -7.45%  
Operating expenses 28.595 M 31.760 M 27.370 M 25.031 M
Selling general and admin 22.401 M 26.069 M 21.327 M 18.624 M
Research and development 6.194 M 5.691 M 6.043 M 6.407 M
Total expenses 67.777 M 74.514 M 58.413 M 56.714 M
    9.94% -21.61% -2.91%  
Operating income 20.564 M 36.717 M 9.358 M 8.961 M
Ebit 20.564 M 36.717 M 9.358 M 8.961 M
Pretax income 19.751 M 36.535 M -6.602 M 4.633 M
    84.98% -118.07% -170.18%  
Income tax 4.411 M 7.783 M 736.000 K -1.072 M
Net income basic 15.340 M 28.752 M -7.338 M 5.705 M
    87.43% -125.52% 177.75%  
Net income 15.340 M 28.752 M -7.338 M 5.705 M
    87.43% -125.52% 177.75%